PMID-sentid Pub_year Sent_text comp_official_name comp_offset protein_name organism prot_offset 29733525-7 2018 CBHA (10 muM) treatment increased (p < .05) the relative expression level of pluripotency-related genes OCT-4 and NANOG, and anti-apoptotic gene BCL-XL, and decreased (p < .05) that of pro-apoptotic gene BAX than in untreated controls but did not affect the relative expression level of apoptosis-related genes p53 and CASPASE3 and epigenetics-related genes DNMT1, DNMT3a and HDAC1. carboxycinnamic acid bishydroxamide 0-4 bcl-2-like protein 1 Bubalus bubalis 148-154 34449946-6 2021 There was a significantly (P<0.05) higher mRNA expression of BCL2L1, GDF9 and BMP15 in the vitrification + retinol group compared to the control group. Vitamin A 107-114 bcl-2-like protein 1 Bubalus bubalis 61-67 22452597-0 2012 Oxygen concentration and cysteamine supplementation during in vitro production of buffalo (Bubalus bubalis) embryos affect mRNA expression of BCL-2, BCL-XL, MCL-1, BAX and BID. Oxygen 0-6 bcl-2-like protein 1 Bubalus bubalis 149-155 22452597-0 2012 Oxygen concentration and cysteamine supplementation during in vitro production of buffalo (Bubalus bubalis) embryos affect mRNA expression of BCL-2, BCL-XL, MCL-1, BAX and BID. Cysteamine 25-35 bcl-2-like protein 1 Bubalus bubalis 149-155 22452597-4 2012 Following cysteamine supplementation, the blastocyst rate and the relative mRNA abundance of BCL-XL and MCL-1 was significantly higher (p < 0.05) and that of BAX but not BID was lower (p < 0.05) at many stages of embryonic development, although it did not affect the percentage of TUNEL positive cells in the blastocysts significantly. Cysteamine 10-20 bcl-2-like protein 1 Bubalus bubalis 93-99